vicadrostat / empagliflozin combination 1 for heart failure

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Dec 2025: Trial registered, NCT07304817
  2. 12 May 2026: Trial started, NCT07304817

The trials

NCT07304817: Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)

State
Under way
Phase
Phase 2
People
100 planned
Started
12 May 2026
Primary completion
Feb 2028
Arms
Vicadrostat
Results
None posted
  1. 26 Dec 2025: Trial registered
  2. 12 May 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.